drugset / Trial / NCT03929718
Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to accurately determine, using an implantable rhythm monitor, the long-term incidence of new atrial fibrillation after ablation of atrial flutter in those treated with spironolactone compared with standard medical therapy.
Timeline
- Start
- 2019-04-24
- Primary completion
- 2025-09
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spironolactone | Small molecule | — | Oral |